BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 24390275)

  • 1. Management of Postprostatectomy Biochemical Relapse With Salvage Radiotherapy: Results of an International Survey.
    Moghanaki D; Urdaneta AI; Karlin JD; Koontz BF; Anscher MS
    Am J Clin Oncol; 2016 Feb; 39(1):64-8. PubMed ID: 24390275
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multi-institutional Evaluation of Elective Nodal Irradiation and/or Androgen Deprivation Therapy with Postprostatectomy Salvage Radiotherapy for Prostate Cancer.
    Ramey SJ; Agrawal S; Abramowitz MC; Moghanaki D; Pisansky TM; Efstathiou JA; Michalski JM; Spratt DE; Hearn JWD; Koontz BF; Liauw SL; Pollack A; Anscher MS; Den RB; Stephans KL; Zietman AL; Lee WR; Stephenson AJ; Tendulkar RD
    Eur Urol; 2018 Jul; 74(1):99-106. PubMed ID: 29128208
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term outcomes after high-dose postprostatectomy salvage radiation treatment.
    Goenka A; Magsanoc JM; Pei X; Schechter M; Kollmeier M; Cox B; Scardino PT; Eastham JA; Zelefsky MJ
    Int J Radiat Oncol Biol Phys; 2012 Sep; 84(1):112-8. PubMed ID: 22300563
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Salvage radiotherapy for macroscopic local recurrences after radical prostatectomy : A national survey on patterns of practice.
    Dal Pra A; Panje C; Zilli T; Arnold W; Brouwer K; Garcia H; Glatzer M; Gomez S; Herrera F; Kaouthar K; Papachristofilou A; Pesce G; Reuter C; Vees H; Zwahlen DR; Engeler D; Putora PM
    Strahlenther Onkol; 2018 Jan; 194(1):9-16. PubMed ID: 28656373
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elective irradiation of pelvic lymph nodes during postprostatectomy salvage radiotherapy.
    Moghanaki D; Koontz BF; Karlin JD; Wan W; Mukhopadhay N; Hagan MP; Anscher MS
    Cancer; 2013 Jan; 119(1):52-60. PubMed ID: 22736478
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identifying appropriate patients for early salvage radiotherapy after prostatectomy.
    Karlin JD; Koontz BF; Freedland SJ; Moul JW; Grob BM; Wan W; Hagan MP; Anscher MS; Moghanaki D
    J Urol; 2013 Oct; 190(4):1410-5. PubMed ID: 23648223
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of Concomitant Androgen Deprivation Therapy in Patients Treated with Early Salvage Radiotherapy for Biochemical Recurrence After Radical Prostatectomy: Long-term Results from a Large, Multi-institutional Series.
    Gandaglia G; Fossati N; Karnes RJ; Boorjian SA; Colicchia M; Bossi A; Seisen T; Cozzarini C; Di Muzio N; Noris Chiorda B; Zaffuto E; Wiegel T; Shariat SF; Goldner G; Joniau S; Battaglia A; Haustermans K; De Meerleer G; Fonteyne V; Ost P; Van Poppel H; Montorsi F; Briganti A
    Eur Urol; 2018 Apr; 73(4):512-518. PubMed ID: 29229176
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of pelvic lymph node irradiation in salvage therapy for patients with prostate cancer with a biochemical relapse following radical prostatectomy.
    Kim BS; Lashkari A; Vongtama R; Lee SP; Parker RG
    Clin Prostate Cancer; 2004 Sep; 3(2):93-7. PubMed ID: 15479492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Salvage radiotherapy in prostate cancer patients with biochemical relapse after radical prostatectomy : Prolongation of prostate-specific antigen doubling time in patients with subsequent biochemical progression.
    Lohm G; Neumann K; Budach V; Wiegel T; Hoecht S; Gollrad J
    Strahlenther Onkol; 2018 Apr; 194(4):325-332. PubMed ID: 29255924
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elective pelvic versus prostate bed-only salvage radiotherapy following radical prostatectomy: A propensity score-matched analysis.
    Song C; Kang HC; Kim JS; Eom KY; Kim IA; Chung JB; Hong SK; Byun SS; Lee SE
    Strahlenther Onkol; 2015 Oct; 191(10):801-9. PubMed ID: 26159555
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Macroscopic locoregional relapse from prostate cancer: which role for salvage radiotherapy?
    Bruni A; Ingrosso G; Trippa F; Di Staso M; Lanfranchi B; Rubino L; Parente S; Frassinelli L; Maranzano E; Santoni R; Sighinolfi MC; Lohr F; Mazzeo E
    Clin Transl Oncol; 2019 Nov; 21(11):1532-1537. PubMed ID: 30868389
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Utilization of Salvage Radiation Therapy for Biochemical Recurrence After Radical Prostatectomy.
    Hawken SR; Spratt DE; Qi J; Linsell SM; Cher ML; Ghani KR; Miller DC; Montie JE; Morgan TM;
    Int J Radiat Oncol Biol Phys; 2019 Aug; 104(5):1030-1034. PubMed ID: 30682490
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Salvage reirradiation for locoregional failure after radiation therapy for prostate cancer: who, when, where and how?
    Créhange G; Roach M; Martin E; Cormier L; Peiffert D; Cochet A; Chapet O; Supiot S; Cosset JM; Bolla M; Chung HT
    Cancer Radiother; 2014 Oct; 18(5-6):524-34. PubMed ID: 25192626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sentinel Lymph Node Dissection to Select Clinically Node-negative Prostate Cancer Patients for Pelvic Radiation Therapy: Effect on Biochemical Recurrence and Systemic Progression.
    Grivas N; Wit E; Pos F; de Jong J; Vegt E; Bex A; Hendricksen K; Horenblas S; KleinJan G; van Rhijn B; van der Poel H
    Int J Radiat Oncol Biol Phys; 2017 Feb; 97(2):347-354. PubMed ID: 28068243
    [TBL] [Abstract][Full Text] [Related]  

  • 15. More Extensive Lymph Node Dissection at Radical Prostatectomy is Associated with Improved Outcomes with Salvage Radiotherapy for Rising Prostate-specific Antigen After Surgery: A Long-term, Multi-institutional Analysis.
    Fossati N; Parker WP; Karnes RJ; Colicchia M; Bossi A; Seisen T; Di Muzio N; Cozzarini C; Noris Chiorda B; Fiorino C; Gandaglia G; Bartkowiak D; Wiegel T; Shariat S; Goldner G; Battaglia A; Joniau S; Haustermans K; De Meerleer G; Fonteyne V; Ost P; Van Poppel H; Montorsi F; Briganti A; Boorjian SA
    Eur Urol; 2018 Aug; 74(2):134-137. PubMed ID: 29544737
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Salvage radiation therapy following radical prostatectomy. A national Danish study.
    Ervandian M; Høyer M; Petersen SE; Sengeløv L; Hansen S; Holmberg M; Sveistrup J; Meidahl Petersen P; Borre M
    Acta Oncol; 2016 May; 55(5):598-603. PubMed ID: 26399602
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radiotherapy after radical prostatectomy: immediate or early delayed?
    Bottke D; Bartkowiak D; Schrader M; Wiegel T
    Strahlenther Onkol; 2012 Dec; 188(12):1096-101. PubMed ID: 23128897
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiotherapy for pelvic nodal recurrences after radical prostatectomy: patient selection in clinical practice.
    Panje C; Zilli T; Dal Pra A; Arnold W; Brouwer K; Garcia Schüler HI; Gomez S; Herrera F; Khanfir K; Papachristofilou A; Pesce G; Reuter C; Vees H; Zwahlen D; Putora PM
    Radiat Oncol; 2019 Oct; 14(1):177. PubMed ID: 31619296
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term Outcome of Prostate Cancer Patients Who Exhibit Biochemical Failure Despite Salvage Radiation Therapy After Radical Prostatectomy.
    Ying J; Wang CJ; Yan J; Liauw SL; Straka C; Pistenmaa D; Xie XJ; Lotan Y; Roehrborn C; Kim DN
    Am J Clin Oncol; 2017 Dec; 40(6):612-620. PubMed ID: 26165416
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improved Metastasis-Free and Survival Outcomes With Early Salvage Radiotherapy in Men With Detectable Prostate-Specific Antigen After Prostatectomy for Prostate Cancer.
    Stish BJ; Pisansky TM; Harmsen WS; Davis BJ; Tzou KS; Choo R; Buskirk SJ
    J Clin Oncol; 2016 Nov; 34(32):3864-3871. PubMed ID: 27480153
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.